|
Paget’s disease |
| Definition: |
| A metabolic bone disease that involves bone destruction and regrowth that results in deformity. |
| Alternative Names: |
| Osteitis deformans |
| Causes, incidence, and risk factors: |
|
The cause of Paget's disease is unknown. Early viral infection and genetic causes have been theorized. The disease occurs worldwide, but is more common in Europe, Australia, and New Zealand where it is seen in up to 5% of the elderly population. The disease is characterized by excessive breakdown of bone tissue, followed by abnormal bone formation. The new bone is structurally enlarged, but weakened and filled with new blood vessels. The disease may localize to one or two areas within the skeleton, or become widespread. Frequently, the pelvis, femur, tibia, vertebrae, clavicle, or humerus are involved. The skull may enlarge head size and cause hearing loss, if the cranial nerves are damaged by the bone growth. |
| Symptoms: |
|
| Signs and tests: |
Tests that may indicate Paget's disease include:
This disease may also alter the results of the following tests: |
| Treatment: |
|
Drug therapy is aimed at suppressing bone breakdown. Currently, there are several classes of medications that inhibit bone resorption and used in the treatment of Paget's disease. These include: bisphosphonates, calcitonin, and plicamycin. The biphosphonates are the first-line treatment and include the following medications: etidronate (Didronel), alendronate (Fosamax), pamidronate (Aredia), tiludronate (Skelid), and risedronate (Actonel). The Calcitonin class includes intranasal (Miacalcin) and subcutaneous (Calcimar) forms. Plicamycin (Mitrhracin) may also be prescribed. Analgesics or nonsteroidal anti-inflammatory medications (NSAIDS) may be given for pain. |
| Support Groups: |
|
Paget Foundation |
| Expectations (prognosis): |
| Disease activity and symptoms can generally be controlled with current medications. Malignant changes of bone occur in less than 1% of people affected. |
| Complications: |
|
| Calling your health care provider: |
|
Call for an appointment with your health care provider if symptoms of Paget's disease develop. |
Reviewed By: Todd T. Brown, M.D., Division of Endocrinology and Metabolism, Johns Hopkins University, Baltimore, MD. Review provided by VeriMed Healthcare Network.
 |
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
